BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 21382311)

  • 1. Likelihood to be helped or harmed can assist in clinical decision-making.
    Citrome L
    J Clin Psychiatry; 2011 Feb; 72(2):261-2; author reply 262. PubMed ID: 21382311
    [No Abstract]   [Full Text] [Related]  

  • 2. Augmentation strategies in the treatment of major depressive disorder. Clinical considerations with atypical antipsychotic augmentation.
    Gitlin MJ
    CNS Spectr; 2007 Dec; 12(12 Suppl 22):13-5. PubMed ID: 18389929
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effect of neuroleptics on depressive symptoms].
    Tabeze JP
    Encephale; 1998 Jul; 24 Spec No 1():38-41. PubMed ID: 9809254
    [No Abstract]   [Full Text] [Related]  

  • 4. Unclear clinical significance of findings in adjunctive aripiprazole for major depressive disorder: comments on article by Marcus et al.
    Tsai AC
    J Clin Psychopharmacol; 2009 Feb; 29(1):91-2; author reply 92-3. PubMed ID: 19142118
    [No Abstract]   [Full Text] [Related]  

  • 5. Aripiprazole in refractory depression?
    Carroll BJ
    J Clin Psychopharmacol; 2009 Feb; 29(1):90-1; author reply 92-3. PubMed ID: 19142117
    [No Abstract]   [Full Text] [Related]  

  • 6. High CSF Tau-protein concentration in delirium induced by high dose psychiatric medication.
    Windhagen A; Wurster U; Kropp S; Ziegenbein M
    Aust N Z J Psychiatry; 2006; 40(11-12):1039-41. PubMed ID: 17054574
    [No Abstract]   [Full Text] [Related]  

  • 7. Efficacy of blonanserin in combination therapy for treatment-resistant depression.
    Kumagai R; Ichimiya Y
    Psychiatry Clin Neurosci; 2009 Aug; 63(4):593-4. PubMed ID: 19659567
    [No Abstract]   [Full Text] [Related]  

  • 8. Atypical antipsychotic augmentation in treatment-resistant major depressive disorder.
    Delgado A; Ehert M
    Conn Med; 2011 Mar; 75(3):153-6. PubMed ID: 21500706
    [No Abstract]   [Full Text] [Related]  

  • 9. [Severe depression : specific features of bipolar disorder].
    Henry C
    Encephale; 2009 Dec; 35 Suppl 7():S261-3. PubMed ID: 20141783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The modern pharmacopoeia: a return to depressive realism?
    Goldberg JF
    Bipolar Disord; 2008 Dec; 10(8):969-72. PubMed ID: 19594511
    [No Abstract]   [Full Text] [Related]  

  • 11. [Mood disorders in pregnancy and post partum period].
    Dorsch VM; Rohde A
    MMW Fortschr Med; 2010 Dec; 152(48):27-30. PubMed ID: 21222331
    [No Abstract]   [Full Text] [Related]  

  • 12. Drugs for depression and bipolar disorder.
    Treat Guidel Med Lett; 2010 May; 8(93):35-42. PubMed ID: 20414177
    [No Abstract]   [Full Text] [Related]  

  • 13. Diagnosis and treatment of a major depressive episode.
    Thase ME
    J Clin Psychiatry; 2009 Oct; 70(10):e37. PubMed ID: 19906336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment and treatment of bipolar II postpartum depression: a review.
    Sharma V; Burt VK; Ritchie HL
    J Affect Disord; 2010 Sep; 125(1-3):18-26. PubMed ID: 19837461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Duloxetine treatment of major depressive episodes in the course of psychotic disorders.
    Zink M; Knopf U; Mase E; Kuwilsky A; Deuschle M
    Pharmacopsychiatry; 2006 May; 39(3):109-11. PubMed ID: 16721699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mixed features and mixed states in psychiatry: from calculus to geometry.
    McIntyre RS
    CNS Spectr; 2017 Apr; 22(2):116-117. PubMed ID: 28264727
    [No Abstract]   [Full Text] [Related]  

  • 17. Antidepressant treatment practice in the face of STAR*D and STEP-BD.
    Cassidy F
    Bipolar Disord; 2008 Dec; 10(8):973-4. PubMed ID: 19594512
    [No Abstract]   [Full Text] [Related]  

  • 18. Safety of electroconvulsive therapy-duloxetine combination.
    Eraslan D; Genc Y; Odabasioglu G; Ergun BM; Ozturk O
    J ECT; 2011 Sep; 27(3):e51-2. PubMed ID: 21865952
    [No Abstract]   [Full Text] [Related]  

  • 19. Use of antipsychotics in the treatment of major depressive disorder in the U.S. Department of Veterans Affairs.
    Mohamed S; Leslie DL; Rosenheck RA
    J Clin Psychiatry; 2009 Jun; 70(6):906-12. PubMed ID: 19422760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjunctive treatment with quetiapine for major depressive disorder: are the benefits of treatment worth the risks?
    Pringsheim T; Gardner D; Patten SB
    BMJ; 2015 Mar; 350():h569. PubMed ID: 25739588
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.